Baird Medical Investment Holdings Limited (NASDAQ:BDMD – Get Free Report) was the target of a significant decline in short interest during the month of July. As of July 15th, there was short interest totaling 19,796 shares, a decline of 40.4% from the June 30th total of 33,197 shares. Based on an average daily volume of 68,010 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.2% of the shares of the stock are sold short.
Institutional Trading of Baird Medical Investment
Several hedge funds and other institutional investors have recently bought and sold shares of BDMD. Citadel Advisors LLC bought a new position in Baird Medical Investment during the third quarter valued at approximately $99,000. Jane Street Group LLC purchased a new position in shares of Baird Medical Investment during the second quarter worth approximately $142,000. Finally, Geode Capital Management LLC raised its stake in shares of Baird Medical Investment by 59.7% during the second quarter. Geode Capital Management LLC now owns 25,442 shares of the company’s stock worth $93,000 after acquiring an additional 9,511 shares in the last quarter. Hedge funds and other institutional investors own 19.78% of the company’s stock.
Baird Medical Investment Trading Down 1.0%
BDMD opened at $1.03 on Friday. The stock has a 50-day moving average price of $1.18 and a 200-day moving average price of $1.53. Baird Medical Investment has a 12-month low of $0.76 and a 12-month high of $3.75.
Wall Street Analysts Forecast Growth
Check Out Our Latest Research Report on BDMD
About Baird Medical Investment
Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.
Featured Stories
- Five stocks we like better than Baird Medical Investment
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Baird Medical Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baird Medical Investment and related companies with MarketBeat.com's FREE daily email newsletter.
